Cellular Therapy View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2020-04-02

AUTHORS

Nirav N. Shah , Adam Levin , Vivek Radhakrishnan , Parameswaran Hari

ABSTRACT

Cell-based immune therapies have been a mainstay for the management of patients with hematological malignancies. While historically allogeneic transplant and donor lymphocyte infusions were the predominant form of cell therapy utilized, recent developments in T cell-based treatments have significantly advanced the field. Specifically, the advent of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell therapies has provided a new powerful tool for patients with relapsed and refractory B cell malignancies. In this chapter, the development of CAR-T cell therapies will be reviewed along with its current and future applications and a detailed description of the potential toxicities associated with this novel treatment. In conclusion, CAR-T cells have revolutionized the field of hematological malignancies and high potential to alter the natural history of these diseases. More... »

PAGES

1-21

Book

TITLE

Contemporary Bone Marrow Transplantation

ISBN

978-3-319-64938-2
978-3-319-64938-2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1

DOI

http://dx.doi.org/10.1007/978-3-319-64938-2_3-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1128848931


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Nirav N.", 
        "id": "sg:person.015270014615.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015270014615.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levin", 
        "givenName": "Adam", 
        "id": "sg:person.014766516573.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014766516573.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tata Medical Center, Kolkata, India", 
          "id": "http://www.grid.ac/institutes/grid.430884.3", 
          "name": [
            "Tata Medical Center, Kolkata, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Radhakrishnan", 
        "givenName": "Vivek", 
        "id": "sg:person.015100736543.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015100736543.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hari", 
        "givenName": "Parameswaran", 
        "id": "sg:person.01170403141.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2020-04-02", 
    "datePublishedReg": "2020-04-02", 
    "description": "Cell-based immune therapies have been a mainstay for the management of patients with hematological malignancies. While historically allogeneic transplant and donor lymphocyte infusions were the predominant form of cell therapy utilized, recent developments in T cell-based treatments have significantly advanced the field. Specifically, the advent of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell therapies has provided a new powerful tool for patients with relapsed and refractory B cell malignancies. In this chapter, the development of CAR-T cell therapies will be reviewed along with its current and future applications and a detailed description of the potential toxicities associated with this novel treatment. In conclusion, CAR-T cells have revolutionized the field of hematological malignancies and high potential to alter the natural history of these diseases.", 
    "editor": [
      {
        "familyName": "Chandy", 
        "givenName": "Mammen", 
        "type": "Person"
      }, 
      {
        "familyName": "Radhakrishnan", 
        "givenName": "Vivek S", 
        "type": "Person"
      }, 
      {
        "familyName": "Sukumaran", 
        "givenName": "Reghu", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-64938-2_3-1", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-64938-2", 
        "978-3-319-64938-2"
      ], 
      "name": "Contemporary Bone Marrow Transplantation", 
      "type": "Book"
    }, 
    "keywords": [
      "cell therapy", 
      "hematological malignancies", 
      "chimeric antigen receptor-modified T-cell therapy", 
      "cell-based immune therapy", 
      "T cell-based treatments", 
      "refractory B-cell malignancies", 
      "CAR T-cell therapy", 
      "donor lymphocyte infusion", 
      "management of patients", 
      "T-cell therapy", 
      "CAR T cells", 
      "B-cell malignancies", 
      "cell-based treatments", 
      "lymphocyte infusion", 
      "allogeneic transplants", 
      "immune therapy", 
      "cell malignancies", 
      "novel treatments", 
      "therapy", 
      "natural history", 
      "cellular therapy", 
      "malignancy", 
      "patients", 
      "treatment", 
      "potential toxicity", 
      "CD19", 
      "transplant", 
      "predominant form", 
      "infusion", 
      "mainstay", 
      "disease", 
      "toxicity", 
      "conclusion", 
      "cells", 
      "management", 
      "development", 
      "history", 
      "new powerful tool", 
      "advent", 
      "potential", 
      "recent developments", 
      "detailed description", 
      "powerful tool", 
      "tool", 
      "high potential", 
      "future applications", 
      "form", 
      "chapter", 
      "description", 
      "field", 
      "applications"
    ], 
    "name": "Cellular Therapy", 
    "pagination": "1-21", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1128848931"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-64938-2_3-1"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-64938-2_3-1", 
      "https://app.dimensions.ai/details/publication/pub.1128848931"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_446.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-64938-2_3-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'


 

This table displays all metadata directly associated to this object as RDF triples.

143 TRIPLES      22 PREDICATES      74 URIs      67 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-64938-2_3-1 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N97ff976078b6465a9bfacc183981ff6d
4 schema:datePublished 2020-04-02
5 schema:datePublishedReg 2020-04-02
6 schema:description Cell-based immune therapies have been a mainstay for the management of patients with hematological malignancies. While historically allogeneic transplant and donor lymphocyte infusions were the predominant form of cell therapy utilized, recent developments in T cell-based treatments have significantly advanced the field. Specifically, the advent of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell therapies has provided a new powerful tool for patients with relapsed and refractory B cell malignancies. In this chapter, the development of CAR-T cell therapies will be reviewed along with its current and future applications and a detailed description of the potential toxicities associated with this novel treatment. In conclusion, CAR-T cells have revolutionized the field of hematological malignancies and high potential to alter the natural history of these diseases.
7 schema:editor N5e9764f550d047ff935b483666070b9c
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Nf799abe894b34ab398f6c29cf20259a1
11 schema:keywords B-cell malignancies
12 CAR T cells
13 CAR T-cell therapy
14 CD19
15 T cell-based treatments
16 T-cell therapy
17 advent
18 allogeneic transplants
19 applications
20 cell malignancies
21 cell therapy
22 cell-based immune therapy
23 cell-based treatments
24 cells
25 cellular therapy
26 chapter
27 chimeric antigen receptor-modified T-cell therapy
28 conclusion
29 description
30 detailed description
31 development
32 disease
33 donor lymphocyte infusion
34 field
35 form
36 future applications
37 hematological malignancies
38 high potential
39 history
40 immune therapy
41 infusion
42 lymphocyte infusion
43 mainstay
44 malignancy
45 management
46 management of patients
47 natural history
48 new powerful tool
49 novel treatments
50 patients
51 potential
52 potential toxicity
53 powerful tool
54 predominant form
55 recent developments
56 refractory B-cell malignancies
57 therapy
58 tool
59 toxicity
60 transplant
61 treatment
62 schema:name Cellular Therapy
63 schema:pagination 1-21
64 schema:productId N4cb4b7aefb95484387f54ae087a59e0d
65 Nab1f765ad64e4feca653c78ad6519760
66 schema:publisher N0acbff540dec46f790f6656ff35a7797
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128848931
68 https://doi.org/10.1007/978-3-319-64938-2_3-1
69 schema:sdDatePublished 2022-10-01T06:59
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher Na45711e7208c4d12b99da9d0b53f5631
72 schema:url https://doi.org/10.1007/978-3-319-64938-2_3-1
73 sgo:license sg:explorer/license/
74 sgo:sdDataset chapters
75 rdf:type schema:Chapter
76 N0acbff540dec46f790f6656ff35a7797 schema:name Springer Nature
77 rdf:type schema:Organisation
78 N342a78052039407aa95bbeaa80245f69 rdf:first Nde3f60e2d8cf4a3b8aab5aadcbf2c99e
79 rdf:rest N49f54fcfac6d470289f0aae797ca68fe
80 N49f54fcfac6d470289f0aae797ca68fe rdf:first Nab3d7234080c4a1e965aa9568965312a
81 rdf:rest rdf:nil
82 N4cb4b7aefb95484387f54ae087a59e0d schema:name doi
83 schema:value 10.1007/978-3-319-64938-2_3-1
84 rdf:type schema:PropertyValue
85 N5e9764f550d047ff935b483666070b9c rdf:first N607221ea80ab43e2a48e0365923074f6
86 rdf:rest N342a78052039407aa95bbeaa80245f69
87 N607221ea80ab43e2a48e0365923074f6 schema:familyName Chandy
88 schema:givenName Mammen
89 rdf:type schema:Person
90 N807195846c794dbeabaf2d32f926dcc8 rdf:first sg:person.014766516573.70
91 rdf:rest Nbdd8273dd7524af5a38ade773e49552f
92 N97ff976078b6465a9bfacc183981ff6d rdf:first sg:person.015270014615.39
93 rdf:rest N807195846c794dbeabaf2d32f926dcc8
94 Na45711e7208c4d12b99da9d0b53f5631 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 Nab1f765ad64e4feca653c78ad6519760 schema:name dimensions_id
97 schema:value pub.1128848931
98 rdf:type schema:PropertyValue
99 Nab3d7234080c4a1e965aa9568965312a schema:familyName Sukumaran
100 schema:givenName Reghu
101 rdf:type schema:Person
102 Nbdd8273dd7524af5a38ade773e49552f rdf:first sg:person.015100736543.25
103 rdf:rest Ndf49789667694e77989ac25bb79f6349
104 Nde3f60e2d8cf4a3b8aab5aadcbf2c99e schema:familyName Radhakrishnan
105 schema:givenName Vivek S
106 rdf:type schema:Person
107 Ndf49789667694e77989ac25bb79f6349 rdf:first sg:person.01170403141.13
108 rdf:rest rdf:nil
109 Nf799abe894b34ab398f6c29cf20259a1 schema:isbn 978-3-319-64938-2
110 schema:name Contemporary Bone Marrow Transplantation
111 rdf:type schema:Book
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
116 schema:name Immunology
117 rdf:type schema:DefinedTerm
118 sg:person.01170403141.13 schema:affiliation grid-institutes:grid.30760.32
119 schema:familyName Hari
120 schema:givenName Parameswaran
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13
122 rdf:type schema:Person
123 sg:person.014766516573.70 schema:affiliation grid-institutes:grid.30760.32
124 schema:familyName Levin
125 schema:givenName Adam
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014766516573.70
127 rdf:type schema:Person
128 sg:person.015100736543.25 schema:affiliation grid-institutes:grid.430884.3
129 schema:familyName Radhakrishnan
130 schema:givenName Vivek
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015100736543.25
132 rdf:type schema:Person
133 sg:person.015270014615.39 schema:affiliation grid-institutes:grid.30760.32
134 schema:familyName Shah
135 schema:givenName Nirav N.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015270014615.39
137 rdf:type schema:Person
138 grid-institutes:grid.30760.32 schema:alternateName Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
139 schema:name Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
140 rdf:type schema:Organization
141 grid-institutes:grid.430884.3 schema:alternateName Tata Medical Center, Kolkata, India
142 schema:name Tata Medical Center, Kolkata, India
143 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...